Phio Pharmaceuticals Corp (PHIO) insider trading
Every open-market stock purchase and sale by Phio Pharmaceuticals Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Ronald Todd Plott (Director) and 2 others bought $59.1K in the last 90 days, growing their stake 16%.
Last 12 months: insiders bought $91.3K (11 buys) and sold $0 (0 sales). Last close $0.87 on Oct 22, 2026.
Recent PHIO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | Ronald Todd Plott (Director) | Bought | $5.2K |
| Sep 28, 2026 | Ronald Todd Plott (Director) | Bought | $5.2K |
| Sep 28, 2026 | Lisa Cabott Carson (CFO) | Bought (not open market) | — |
| Sep 28, 2026 | Ronald Todd Plott (Director) | Bought (not open market) | — |
| Sep 28, 2026 | Robert J Bitterman (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Patricia A Bradford (Director) | Bought | $6.6K |
| Sep 22, 2026 | Robert J Bitterman (CEO) | Bought | $2.1K |
| Sep 15, 2026 | Patricia A Bradford (Director) | Bought | $12.4K |
| Sep 11, 2026 | Robert J Bitterman (CEO) | Sold (not open market) | $70.6K |
| Sep 11, 2026 | Lisa Cabott Carson (CFO) | Sold (not open market) | $13.3K |
| Aug 19, 2026 | Ronald Todd Plott (Director) | Bought | $17.1K |
| Aug 18, 2026 | Robert J Bitterman (CEO) | Bought | $10.6K |
| Jun 26, 2026 | Robert J Bitterman (CEO) | Bought | $9.9K |
| Feb 5, 2026 | Patricia A Bradford (Director) | Bought (not open market) | — |
| Feb 5, 2026 | Curtis Lockshin (Director) | Bought (not open market) | — |
| Feb 5, 2026 | David H Deming (Director) | Bought (not open market) | — |
| Feb 5, 2026 | Jonathan E Freeman (Director) | Bought (not open market) | — |
| Feb 5, 2026 | Lisa Cabott Carson (CFO) | Bought (not open market) | — |
| Feb 5, 2026 | Robert J Bitterman (CEO) | Bought (not open market) | — |
| Dec 31, 2025 | Robert J Bitterman (CEO) | Bought | $5.2K |
| Dec 23, 2025 | Robert J Bitterman (CEO) | Bought | $5.1K |
| Nov 21, 2025 | Robert J Bitterman (CEO) | Bought | $5.7K |
| Nov 18, 2025 | Robert J Bitterman (CEO) | Bought | $6.3K |
Who's trading PHIO
- Ronald Todd Plott, Director: bought $27.4K (3 buys), last Sep 29, 2026
- Robert J Bitterman, CEO: bought $44.9K (7 buys), last Sep 28, 2026
- Lisa Cabott Carson, CFO: other filings, last Sep 28, 2026
- Patricia A Bradford, Director: bought $18.9K (2 buys), last Sep 24, 2026
- Jonathan E Freeman, Director: other filings, last Feb 5, 2026
- Curtis Lockshin, Director: other filings, last Feb 5, 2026
- David H Deming, Director: other filings, last Feb 5, 2026
Get free alerts when an insider at Phio Pharmaceuticals Corp files a new trade →